Cancers are the leading cause of DALY and the second leading cause of mortality, among the most impactful pathologies for patients today, along with cardiovascular diseases. Every day, 1,000 people die from cancer in Italy, but at the same time 6 out of 10 cancer patients survive, thanks to improvements in diagnosis and treatment.
In addition to the impact on the patient’s health, non-communicable diseases also have a significant impact on healthcare and social spending. It is now estimated that in Europe the costs of chronic non-communicable diseases amount to 70-80% of the total budget that countries spend on healthcare, to which must be added the resources that individuals use for care and assistance.
The latest medical revolutions in this area are new healthcare models, which also require new models of evaluation and funding.
- L’evoluzione nella diagnosi e trattamento dei pazienti oncologici e le opportunità del digitale
- I cambiamenti nella spesa sanitaria e spesa previdenziale/assistenziale in una versione integrata: il caso dei tumori in Italia
- Il valore delle CAR-T
- Dimensioni, impatti e confini del tumore alla mammella metastatico. Azioni per aumentare il valore per il paziente e per il sistema